Previous 10 | Next 10 |
AIkido Pharma Inc. Announces Exercise of Option to Purchase Additional Shares in Bought Deal Offering PR Newswire NEW YORK , Feb. 23, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the underwriter of i...
AIkido Pharma ([[AIKI]] -0.9%) announces an update on its broad spectrum anti-viral platform compounds with the potential to treat influenza, COVID-19, Ebola and other viral infections.The initial two lead compounds, which target the SKI complex in humans, have been optimized throug...
AIkido Pharma Provides Update on its Antiviral Platform, Including the Virus That Causes COVID-19 Artificial Intelligence is optimizing drug development PR Newswire NEW YORK , Feb. 22, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or t...
AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock PR Newswire NEW YORK , Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced ...
Gainers: CLPS (CLPS) +275%.Comstock Mining (LODE) +176%.TDH Holdings (PETZ) +134%.Dogness (DOGZ) +54%.Onconova Therapeutics (ONTX) +50%.EHang (EH) +42%.Processa Pharmaceuticals (PCSA) +34%.ZW Data Action Technologies (CNET) +33%.Ebang International (EBON) +22%.China Natural Resource...
Interpace Biosciences (IDXG) -28% on Nasdaq delisting.Seanergy Maritime (SHIP) -23% on capital raise.KAR Auction Services (KAR) -22% on Q4 earnings.AIkido Pharma (AIKI) -20% on capital raise.Socket Mobile (SCKT) -20%.ALJ Regional (ALJJ) -17%.Immunic (IMUX)...
AIkido Pharma's (AIKI) underwriter has agreed to increase the size of the previous offering and purchase ~46.9M common shares at $1.60/share.Expected gross proceeds are ~$75M. Underwriter's over-allotment is an additional ~7.03M shares. Net proceeds will be used for working capital and genera...
AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million PR Newswire NEW YORK , Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the u...
AIkido Pharma (AIKI) announced that it has entered into an underwriting agreement with H.C. Wainwright, under which the underwriter has agreed to purchase 6.25M shares at a price of $1.60/share.The company also has granted to the underwriter a 30-day option to purchase up to an additiona...
AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock PR Newswire NEW YORK , Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has entered into an underwriting agreemen...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Inc. Company Name:
AIKI Stock Symbol:
NASDAQ Market:
AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK , Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AI...
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW YORK , Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (...
AIkido Share Repurchase Continues PR Newswire NEW YORK , Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share Repurchase Program") authori...